[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"massive-rotator-cuff-tears\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:massive-rotator-cuff-tears":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,41,70],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100650246","voll-non-degradable-shoulder-spacer-fih-study-100650246",false,"NCT07745647","Voll Non-Degradable Shoulder Spacer FIH Study","A Single-Center, Prospective, First-In-Human Study to Evaluate the Initial Safety and Effectiveness of a Non-Degradable Shoulder Spacer in Patients With Symptomatic Massive Rotator Cuff Tears","Inclusion Criteria:\n\n* Full thickness MRCT.\n* Male or female patients ≥ fifty (50) years of age, in general good health, independent, and can comply with all post-operative evaluations and visits.\n\nExclusion Criteria:\n\n* Documented evidence of a history of drug\u002Falcohol abuse within 1 year of enrollment.\n* Concurrent participation in any other investigational clinical study.","ALL","50 Years",{"count":19,"type":20},10,"ESTIMATED","INTERVENTIONAL",[23],"NA","The Voll Non-Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a non-degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).",[26,27],"Massive Rotator Cuff Tears","Massive Rotator Cuff Tear","NOT_YET_RECRUITING","2026-07-29",{"date":31,"type":32},"2026-08-04","ACTUAL",{"date":34,"type":20},"2026-09",{"date":36,"type":20},"2028-09",{"name":38,"class":39},"Voll Medical Technologies Ltd.","INDUSTRY",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":16,"minAge":48,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":21,"phases":51,"briefSummary":52,"conditions":53,"keywords":54,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":40},"100604832","latissimus-dorsi-tendon-transfer-vs-superior-capsular-reconstruction-in-massive-rotator-cuff-tears-100604832","NCT07154641","Latissimus Dorsi Tendon Transfer vs. Superior Capsular Reconstruction in Massive Rotator Cuff Tears","Comparison Between Latissimus Dorsi Tendon Transfer and Superior Capsular Reconstruction in Massive Rotator Cuff Tears: A Randomised Controlled Trial.","Inclusion Criteria:\n\nAdult patients (over 18 years old). Massive rotator cuff tear diagnosis based on shoulder MRI. -\n\nExclusion Criteria:\n\nAdvanced glenohumeral arthritis (Hamada ≥3). Deltoid dysfunction. Irrepearable subscapularis tear. Infection. Prior shoulder surgery. Shoulder stiffness.\n\n\\-","18 Years",{"count":50,"type":20},44,[23],"The goal of this clinical trial is to compare the results of two surgical operations for the treatment of massive rotator cuff tears: latissimus dorsi tendon transfer (LDT) and superior capsular reconstruction (SCR).\n\nThe main question it wants to answer is which of the two operations provides better functional results, as measured by two patient-reported questionaires: the American Shoulder and Elbow Surgeons (ASES) score and the Constant-Murley score.\n\nThe patients will be randomly assigned to one of two groups according to the surgery they will undergo (LDT or SCR). They will be examined clinically and asked to fill the questionaires before the surgery, at 6 weeks and at 3, 6, 12 and 24 months after surgery.",[26],[55,56,57,58],"Massive rotator cuff tears","Latissimus dorsi tendon transfer","Superior capsular reconstruction","rotator cuff tears","RECRUITING","2025-08-26",{"date":62,"type":32},"2025-09-04",{"date":64,"type":32},"2025-07-02",{"date":66,"type":20},"2029-05",{"name":68,"class":69},"Konstantopoulio-Patission General Hospital of Nea Ionia","OTHER",{"id":71,"slug":72,"hasResults":11,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":16,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":4,"studyType":21,"phases":82,"briefSummary":83,"conditions":84,"keywords":85,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":98},"100406400","arthroscopic-treatment-of-massive-rotator-cuff-tears-with-debridement-and-biodegradable-spacer-100406400","NCT04571918","Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and Biodegradable Spacer.","Arthroscopic Treatment of Massive Rotator Cuff Tears With Debridement and or Biodegradable Spacer: a Prospective Randomized Clinical Trial.","AMRIS","Inclusion Criteria:\n\n* Patients suffering from a symptomatic massive rotator cuff tear, with fatty infiltration grade 3 or 4 classified on CT by Goutallier et al, or MRI by Fuchs classification.\n* Persistent pain for at least 3 months, with documented failure of conservative treatment\n* Age ranging from 60 years of age to 85 years of age\n\nExclusion Criteria:\n\n* Significant shoulder osteoarthritis in the affected shoulder, Hamada classification \\>2.\n* Total rupture of subscapularis tendon and\u002For teres minor, classified B and E in the Collins classification.\n* Comorbidity to the degree that the patient will not be able to participate in the follow up program.","60 Years","85 Years",{"count":81,"type":20},50,[23],"Massive rotator cuff tears are common in the adult population. It is estimated that about 12 % of adults 60 years of age or older suffer from a rotator cuff injury. About 40 % of these injuries are classified as massive rotator cuff tears (MRCT). MRCT propose a great challenge to the affected patient and its doctor. It is a painful condition with few treatment options.\n\nThe study aims to investigate the operative treatment for MRCT with the new treatment option proposed by Senecovic. Insertion of a biodegradable balloon as a subacromial spacer has proven promising results so far. To this date there is only small and non-randomized studies on the subject. AMRIS are planning to do a randomized controlled study where group A is treated with arthroscopic debridement, biceps tenotomy and biodegradable spacer, while group B, the control group are treated with arthroscopic debridement and biceps tenotomy.",[26],[86,87,88],"Ballon spacer","Biodegradable spacer","Subacromial spacer","2020-09-25",{"date":91,"type":32},"2020-10-01",{"date":93,"type":20},"2020-11-01",{"date":95,"type":20},"2029-09-01",{"name":97,"class":69},"Oslo University Hospital",2]